FDA Warns of Acute Pancreatitis Associated with Byetta
The FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta (exenatide), a drug used to treat adults with type 2 diabetes. An association between Byetta and acute pancreatitis is suspected in some of these cases. Amylin Pharmaceuticals, Inc., the maker of Byetta, has agreed to include information about acute pancreatitis in the "Precautions" section of the product label.
Continue reading "FDA Warns of Acute Pancreatitis Associated with Byetta" »
